NCT00144560
Completed
Not Applicable
An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA
ConditionsRheumatoid Arthritis
DrugsMRA(Tocilizumab)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- Chugai Pharmaceutical
- Enrollment
- 31
- Primary Endpoint
- 20% improvement based on the ACR criteria compared with the baseline value.
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
This is an open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
20% improvement based on the ACR criteria compared with the baseline value.
Time Frame: throughout study
Secondary Outcomes
- Time courses taken from baseline values for DAS28, for ACR20%, 50%, and 70% improvement, and for each ACR core set variable.(Week 0,Week 1, Week 2)
Similar Trials
Completed
Phase 1
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult MenHealthy VolunteersNCT01588782Janssen Research & Development, LLC20
Completed
Phase 1
Lesinurad Interaction Study With RanitidineHealthyNCT01908257Ardea Biosciences, Inc.16
Completed
Phase 1
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male SubjectsBenign Prostate HyperplasiaNCT02839122Yuyu Pharma, Inc.28
Completed
Phase 1
Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy AdultsPainNCT06523595Vertex Pharmaceuticals Incorporated31
Completed
Phase 1
Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy ParticipantsHealthy VolunteersNCT05665647Jiangsu Simcere Pharmaceutical Co., Ltd.36